AstraZeneca - Research-Based BioPharmaceutical Company

Skip to content
Skip to navigation
Skip to footer

Our vaccine commitment

“Female representation, particularly in leadership, is crucial for healthy societies. We are committed to breaking down barriers and empowering the girls of today to be the leaders of tomorrow. We are proud to continue our support of #GirlsBelongHere in partnership with Plan International, and are committed to advancing gender equality around the world.”

Publications

Our innovative science means a strong track-record of publication in peer-reviewed journals, contributing to the foundation of scientific advancement.

View our publications

We have

160

projects in our pipeline

View pipeline

Explore our technology

Our Cambridge site (UK) is one of AstraZeneca's three global science centres

Explore all our science centres

Wherever we work in the world, we aim to make a positive impact on people and the communities in which they live

Corporate Press Release

Imfinzi plus tremelimumab significantly improved overall survival in HIMALAYA Phase III trial in 1st-line unresectable liver cancer

15 October 2021

Corporate Press Release

AZD7442 reduced risk of developing severe COVID-19 or death in TACKLE Phase III outpatient treatment trial

11 October 2021